HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

ICI 35868 (Diprivan): a new intravenous anaesthetic. A comparison with Althesin.

Abstract
ICI 35868 (Diprivan), 1-2 mg/kg was used to induce anaesthesia in 20 patients, and the results compared with induction of anaesthesia by Althesin 0.5 ml/kg given to a similar group of 20 patients. ICI 35868 was effective in inducing anaesthesia, but produced more respiratory depression, and cardiovascular effects which were significantly different from those produced by Althesin. ICI 35868 gave a smoother induction. It is concluded that ICI 35868 is a promising new induction agent which may also find application for the maintenance of anaesthesia.
AuthorsB Kay, D K Stephenson
JournalAnaesthesia (Anaesthesia) Vol. 35 Issue 12 Pg. 1182-7 (Dec 1980) ISSN: 0003-2409 [Print] England
PMID7006442 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • Anesthetics
  • Phenols
  • Alfaxalone Alfadolone Mixture
  • Propofol
Topics
  • Adult
  • Alfaxalone Alfadolone Mixture (pharmacology)
  • Anesthesia, Intravenous
  • Anesthetics (pharmacology)
  • Clinical Trials as Topic
  • Double-Blind Method
  • Drug Administration Schedule
  • Female
  • Hemodynamics (drug effects)
  • Humans
  • Male
  • Phenols (pharmacology)
  • Propofol
  • Respiration (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: